APA (7th ed.) Citation

L, V., A, L., N, S., ME, P., RJ, E., C, G., . . . T, B. (2022). p53 immunohistochemistry in endometrial cancer: Clinical and molecular correlates in the PORTEC-3 trial. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 35(10), 1475. https://doi.org/10.1038/s41379-022-01102-x

Chicago Style (17th ed.) Citation

L, Vermij, et al. "P53 Immunohistochemistry in Endometrial Cancer: Clinical and Molecular Correlates in the PORTEC-3 Trial." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 35, no. 10 (2022): 1475. https://doi.org/10.1038/s41379-022-01102-x.

MLA (9th ed.) Citation

L, Vermij, et al. "P53 Immunohistochemistry in Endometrial Cancer: Clinical and Molecular Correlates in the PORTEC-3 Trial." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 35, no. 10, 2022, p. 1475, https://doi.org/10.1038/s41379-022-01102-x.